These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11844863)

  • 1. B-cell deficiency and type 1 diabetes.
    Noorchashm H; Greeley SA; Naji A
    N Engl J Med; 2002 Feb; 346(7):538-9. PubMed ID: 11844863
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell deficiency and type 1 diabetes.
    Farid NR
    N Engl J Med; 2002 Feb; 346(7):538-9. PubMed ID: 11858222
    [No Abstract]   [Full Text] [Related]  

  • 3. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile autoimmune diabetes: a pathogenic role for maternal antibodies?
    von Herrath M; Bach JF
    Nat Med; 2002 Apr; 8(4):331-3. PubMed ID: 11927933
    [No Abstract]   [Full Text] [Related]  

  • 6. The natural autoantibody repertoire and autoimmune disease.
    Quintana FJ; Cohen IR
    Biomed Pharmacother; 2004 Jun; 58(5):276-81. PubMed ID: 15194162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Non Obese Diabetic (NOD) mouse, as a model of T cell mediated autoimmune disease.
    Bach JF
    C R Acad Sci III; 1992; 314(9 Suppl):45-6. PubMed ID: 1422905
    [No Abstract]   [Full Text] [Related]  

  • 9. Closing in on type 1 diabetes.
    McDevitt H
    N Engl J Med; 2001 Oct; 345(14):1060-1. PubMed ID: 11586961
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice.
    Leiter EH; Serreze DV
    Reg Immunol; 1992; 4(5):263-73. PubMed ID: 1290746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the timing of immunologic priming in autoimmune insulitis in NOD mice.
    Kai N; Motojima K; Shiogama T; Terada M; Tamaki S; Tsunoda T; Kanematsu T
    Transplant Proc; 1992 Jun; 24(3):1040-1. PubMed ID: 1376511
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of type 1 diabetes despite severe hereditary B-cell deficiency.
    Martin S; Wolf-Eichbaum D; Duinkerken G; Scherbaum WA; Kolb H; Noordzij JG; Roep BO
    N Engl J Med; 2001 Oct; 345(14):1036-40. PubMed ID: 11586956
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
    Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
    J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
    Balasa B; Van Gunst K; Sarvetnick N
    Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases.
    Alyanakian MA; You S; Damotte D; Gouarin C; Esling A; Garcia C; Havouis S; Chatenoud L; Bach JF
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15806-11. PubMed ID: 14673094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice.
    Baxter AG; Horsfall AC; Healey D; Ozegbe P; Day S; Williams DG; Cooke A
    Immunology; 1994 Oct; 83(2):227-31. PubMed ID: 7835939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.
    Serreze DV; Fleming SA; Chapman HD; Richard SD; Leiter EH; Tisch RM
    J Immunol; 1998 Oct; 161(8):3912-8. PubMed ID: 9780157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.